Waterloo Capital’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.83M | Buy |
20,619
+2,119
| +11% | +$393K | 0.31% | 76 |
|
|
2025
Q1 | $3.88M | Buy |
18,500
+3,125
| +20% | +$655K | 0.36% | 71 |
|
|
2024
Q4 | $2.73M | Buy |
15,375
+307
| +2% | +$54.6K | 0.29% | 88 |
|
|
2024
Q3 | $2.98M | Buy |
15,068
+4,197
| +39% | +$829K | 0.32% | 78 |
|
|
2024
Q2 | $1.86M | Sell |
10,871
-1,366
| -11% | -$234K | 0.22% | 102 |
|
|
2024
Q1 | $2.23M | Buy |
12,237
+95
| +0.8% | +$17.3K | 0.28% | 87 |
|
|
2023
Q4 | $1.88M | Buy |
12,142
+10,333
| +571% | +$1.6M | 0.3% | 82 |
|
|
2023
Q3 | $270K | Buy |
+1,809
| New | +$270K | 0.08% | 155 |
|
|
2023
Q2 | – | Sell |
-2,529
| Closed | -$403K | – | 207 |
|
|
2023
Q1 | $403K | Buy |
+2,529
| New | +$403K | 0.12% | 102 |
|